• About us
  • Advertise
  • Contact
  • Nominate
  • Client’s Voice
  • Login
  • Register
📖 Magazine
The Global Economics
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
  • Home
  • Banking
  • Non Banking
  • Markets
  • Infrastructure
  • Lifestyle
  • FeatureNew
  • Awards
No Result
View All Result
The Global Economics
No Result
View All Result
Home Top Stories

Global Vaccine Inequity for Poor Countries

The administration of the coronavirus vaccine is lagging, plagued by multiple setbacks

The Global Economics by The Global Economics
April 1, 2021
in Top Stories
Reading Time: 1 min read
0
Covid-19: Global Vaccine Inequity for Poor Countries

Covid-19: Global Vaccine Inequity for Poor Countries

413
SHARES
2.3k
VIEWS
FacebookTwitterRedditWhatsAppLinkedInFacebook

More than a year after the novel coronavirus was identified, vaccination has been unleashed with more demand outpacing vaccine supply.  

Currently, 10 vaccines including Pzifer-BioNTech, Johnson and Johnson, and AstraZeneca are being administered worldwide. 

As the supply of Covid-19 vaccines is monitored, it’s noticed that the richer countries in Europe and North America have reserved and cleared the shelves, creating a massive gap in access to the vaccine. 

The latest trend shows barely three-quarters of vaccines reaching a handful of 10 countries—all while 30 developing and under-developed countries are likely to wait for two more years before vaccinating their population. 

As the wealthiest countries are deft with influence, negotiating heft, and cash—if all their claims are delivered, the U.S. and Britain could inoculate four times, and the European Union could vaccinate its population twice. 

Several rich countries have joined the U.S. bandwagon in pre-ordering way more than requirements—stymying poor nations by shortages and supply disruptions. According to world reports, the U.S. has claimed as many as 100 million doses from Pzifer-BioNTech and pre-ordered from Johnson and Johnson, and many more in the pipeline. Notably, all these vaccines have been developed as two-dose treatments for residents. 

Initiatives like Covax have backed the manufacturing and development of vaccine candidates like AstraZeneca—only to struggle to raise enough capital that could barely inoculate 20% of each poor country’s population.

Tags: astrazenecaCovid19demandoutpacingsupplyGlobal VaccineinequitymassivegappoorcountirespziferbiontechrichercountriesVaccine
The Global Economics

The Global Economics

The Global Economics Limited is a UK based financial publication and a bi-annual business magazine giving thoughful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

Related Posts

US and Ukraine Sign the High-Stakes Critical Mineral Pact
Trending

US and Ukraine Sign the High-Stakes Critical Mineral Pact

by The Global Economics
May 1, 2025
Global Tariffs Can't Slow Down China’s Growing Steel Production
Global Trade

Global Tariffs Can’t Slow Down China’s Growing Steel Production

by The Global Economics
April 16, 2025
Google to Finalize its Biggest Deal with Cyber-Security Startup Wiz
Technology

Google to Finalize its Biggest Deal with Cyber-Security Startup Wiz

by The Global Economics
March 19, 2025
Alibaba's RISC-V Chip Will Be a Game-Changer for China's Semiconductor Industry
Technology

Alibaba’s RISC-V Chip Will Be a Game-Changer for China’s Semiconductor Industry

by The Global Economics
March 10, 2025
Cop16 Deal Secures Billions of Dollars for Biodiversity Protection
Top Stories

Cop16 Deal Secures Billions of Dollars for Biodiversity Protection

by The Global Economics
February 28, 2025
Twitter Youtube LinkedIn Soundcloud
the global economics logo

The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.

DMCA.com Protection Status

  • Privacy
  • Legal
  • Terms of Use
  • Client’s Voice
  • Server Status

norton verified - the global economics

Latest Posts

EU Proposes to Ban Russian Gas Imports By the End of 2027

EU Proposes to Ban Russian Gas Imports By the End of 2027

May 21, 2025
Thailand Aims to Ease US Deficit and Avert 36% Tariffs

Thailand Aims to Ease US Deficit and Avert 36% Tariffs

May 20, 2025
After Years in the Shadows, Emerging Markets Are Back in the Spotlight

After Years in the Shadows, Emerging Markets Are Back in the Spotlight

May 19, 2025
Download The Global Economics PWA to your mobile or Desktop
PWA App Download
Download The Global Economics Android App to your mobile or Desktop
Android App
Download The Global Economics IOS App to your mobile or Desktop
IOS App

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

Welcome Back!

Sign In with Facebook
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Linked In
OR

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • About us
  • Awards
  • Magazine
  • Client’s Voice
  • Exclusive Coverage
  • Nominate
  • Login
  • Sign Up

All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version